Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples